Here's another one, published in Nature Medicine: https://www.nature.com/articles/s41591-021-01630-0 https://www.nature.com/articles/s41591-021-01630-0 I haven

Here's another one, published in Nature Medicine: https://www.nature.com/articles/s41591-021-01630-0 https://www.nature.com/articles/s41591-021-01630-0 I haven't read it beyond the abstract. We estimated an extra two (95% confidence interval (CI) 0, 3), one (95% CI 0, 2) and six (95% CI 2, 8) myocarditis events per 1 million people vaccinated with ChAdOx1, BNT162b2 and mRNA-1273, respectively, in the 28 days following a first dose and an extra ten (95% CI 7, 11) myocarditis events per 1 million vaccinated in the 28 days after a second dose of mRNA-1273. This compares with an extra 40 (95% CI 38, 41) myocarditis events per 1 million patients in the 28 days following a SARS-CoV-2 positive test.